Piperidine, 1-[[8-[(3,5-dioxo-4-isoxazolidinyl)oxy]-5-quinolinyl]sulfonyl]- (156692-20-5)

Identification
Name:	Piperidine, 1-[[8-[(3,5-dioxo-4-isoxazolidinyl)oxy]-5-quinolinyl]sulfonyl]-
CAS:	156692-20-5
Molecular Formula:	C₁₇H₁₇N₃O₆S
Molecular Structure:
Properties
Safety Data

Other Product

Morpholine, 4-[[8-[(3,5-dioxo-4-isoxazolidinyl)oxy]-5-quinolinyl]sulfonyl]-
Piperidine,1-[[8-[(3,5-dioxo-1-phenyl-4-pyrazolidinyl)oxy]-5-quinolinyl]sulfonyl]-
Piperidine, 1-[[8-[(3,5-dioxo-4-pyrazolidinyl)oxy]-5-quinolinyl]sulfonyl]-
Piperidine,1-[[8-[(3,5-dimethyl-4H-pyrazol-4-yl)oxy]-5-quinolinyl]sulfonyl]-
Piperidine,1-[[8-[(4,5-dihydro-3,5-dimethyl-4-isoxazolyl)oxy]-5-quinolinyl]sulfonyl]-
Morpholine,4-[[8-[(3,5-dioxo-1-phenyl-4-pyrazolidinyl)oxy]-5-quinolinyl]sulfonyl]-
Piperidine,1-[[8-[(2,5-dihydro-4,6-dimethyl-2-oxo-5-pyrimidinyl)oxy]-5-quinolinyl]sulfonyl]-
Piperidine,1-[[8-[(hexahydro-2,4,6-trioxo-5-pyrimidinyl)oxy]-5-quinolinyl]sulfonyl]-
Piperidine, 1-[[8-(1-acetyl-2-oxopropoxy)-5-quinolinyl]sulfonyl]-
Piperidine, 1-[(8-hydroxy-5-quinolinyl)sulfonyl]-, sodium salt
Morpholine, 4-[[8-[(3,5-dioxo-4-pyrazolidinyl)oxy]-5-quinolinyl]sulfonyl]-
Piperidine,1-[5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-
Piperidine,1-[5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-, (S)-
Morpholine,4-[[8-[(4,5-dihydro-3-methyl-5-oxo-4-isoxazolyl)oxy]-5-quinolinyl]sulfonyl]-
Piperidine,1-[5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-
Piperidine, 1-[2-[(6,7-dimethoxy-4-quinolinyl)oxy]-5-methylbenzoyl]-
Acetamide,2-[[5-(1-piperidinylsulfonyl)-8-quinolinyl]oxy]-N-[4-[(2-thiazolylamino)sulfonyl]phenyl]-
Morpholine, 4-[[8-(1-acetyl-2-oxopropoxy)-5-quinolinyl]sulfonyl]-
Piperazine, 1-bromo-4-[(8-chloro-5-quinolinyl)sulfonyl]-
Piperazine, 1-bromo-4-[(8-chloro-5-quinolinyl)sulfonyl]-,monohydrochloride